Pei-Shan Wu

Development of robust genotype 1a hepatitis C replicons harboring adaptive mutations for facilitating the antiviral drug discovery and study of virus replication.

A. Yueh, Han-Shu Hu, J. Chern, 2018, Journal of virological methods.

Resistance Studies of a Dithiazol Analogue, DBPR110, as a Potential Hepatitis C Virus NS5A Inhibitor in Replicon Systems

A. Yueh, Y. Chao, Su-Ying Wu, 2012, Antimicrobial Agents and Chemotherapy.

A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.

C. Chen, A. Yueh, Szu-Huei Wu, 2019, Antiviral research.

Resistance Analysis and Characterization of a Thiazole Analogue, BP008, as a Potent Hepatitis C Virus NS5A Inhibitor

A. Yueh, Y. Chao, T. Yeh, 2011, Antimicrobial Agents and Chemotherapy.

Microinjection of Western Corn Rootworm, Diabrotica virgifera virgifera, Embryos for Germline Transformation, or CRISPR/Cas9 Genome Editing.

M. Lorenzen, N. Grubbs, Pei-Shan Wu, 2018, Journal of visualized experiments : JoVE.